| | | | | | | | | | |
|
|
| Dockets Entered
On May 5, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket
#
|
| Title
|
|
|
|
|
| 1994P-0390
|
| Adopt Amendments Governing Health Claims & Nutrient Claims
|
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim "Healthy" & Health Claims
|
|
|
| 1997D-0411
|
| (BSE) in Products for Human Use; Guidance for Industry.
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1999F-4372
|
| National Fisheries Institute and the Louisiana Dep of Agricu
|
|
|
| 1999F-5321
|
| Food Safety & Inspection service safe use of ionizing radiai
|
|
|
| 1999F-5322
|
| Ionizing Radiation for the Treatment of Food
|
|
|
| 1999F-5522
|
| Ionizing radiation /control of Food-borne pathogens safe use
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| 2000D-1350
|
| Combined Oral Contraceptives/Labeling/Healthcare Providers
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
| 2001F-0047
|
| Foodborne pathogens in raw-frozen-cooked-partially cooked
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| 2002N-0276
|
| Bioterrorism Preparedness; Registration of Food Facilities
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2002V-0415
|
| LAD-01 Medical Laser Product
|
|
|
| 2003D-0493
|
| Guidance on Powder Blends and Finished Dosage Units -- Stratified In-Process Dosage Unit Sampling and Assessmen
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| 2003N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point (HAACP); Procedures for the Safe and Sanitary Processing and Importing of Jui
|
|
|
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
|
| 2004D-0182
|
| Guidance for Industry on Combination Products, Timeliness of Premarket Review, Dispute Resolution
|
|
|
| 2004D-0210
|
| Guidance: Clinical Trial Design for Hip Replacement Systems
|
|
|
| 2004N-0076
|
| Food and Color Additives and Generally Recognized As Safe Substances; Technical Amendments
|
|
|
| 2004N-0087
|
| Request for Comment on Generic Drug Issues
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
| 2004N-0133
|
| Part 11, Electronic Record; Electronic Signatures; Public Meeting
|
|
|
| 2004P-0140
|
| Rescind the March 1, 2004 Dear Applicant Letter Regarding Metaxalone Labeling
|
|
|
| 2004V-0211
|
| Variance for Mobolazer ML 10 300
|
|
|
| 1994P-0390
|
| Adopt Amendments Governing Health Claims & Nutrient Claims
|
|
|
| NPR
3
|
| FDA
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim "Healthy" & Health Claims
|
|
|
| NPR
3
|
| FDA
|
| Vol #:
|
| 5
|
|
|
| 1997D-0411
|
| (BSE) in Products for Human Use; Guidance for Industry.
|
|
|
| C
15
|
| Gelatin Manufacturers of Europe (GME) and the Gelatin Manufacturers Institute of America (GMIA)
|
| Vol #:
|
| 2
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| C 7433
|
| J. Green
|
| Vol #:
|
| 307
|
|
|
| EMC 4223
|
| R. Dean
|
| Vol #:
|
| 304
|
|
|
| EMC 4224
|
| R. Dean
|
| Vol #:
|
| 304
|
|
|
| EMC 4225
|
| A. Spears
|
| Vol #:
|
| 304
|
|
|
| 1999F-4372
|
| National Fisheries Institute and the Louisiana Dep of Agricu
|
|
|
| EMC 471
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| EMC 472
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| 1999F-5321
|
| Food Safety & Inspection service safe use of ionizing radiai
|
|
|
| EMC 374
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| EMC 375
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| 1999F-5322
|
| Ionizing Radiation for the Treatment of Food
|
|
|
| EMC 373
|
| M. Chambers
|
| Vol #:
|
| 6
|
|
|
| EMC 374
|
| M. Chambers
|
| Vol #:
|
| 6
|
|
|
| 1999F-5522
|
| Ionizing radiation /control of Food-borne pathogens safe use
|
|
|
| EMC 376
|
| M. Chambers
|
| Vol #:
|
| 6
|
|
|
| EMC 377
|
| M. Chambers
|
| Vol #:
|
| 6
|
|
|
| 1999N-4282
|
| Biotechnology in the Year 2000 and Beyond; Public Meetings
|
|
|
| EMC 4212
|
| M. Chambers
|
| Vol #:
|
| 515
|
|
|
| EMC 4213
|
| M. Chambers
|
| Vol #:
|
| 515
|
|
|
| 1999P-2630
|
| Establish a Daily Value for "added sugars"
|
|
|
| EMC 782
|
| B. Erlandsen
|
| Vol #:
|
| 33
|
|
|
| 2000D-1350
|
| Combined Oral Contraceptives/Labeling/Healthcare Providers
|
|
|
| C
18
|
| Wyeth Pharmaceuticals
|
| Vol #:
|
| 6
|
|
|
| C
19
|
| Planned Parenthood Federation of America, Inc. (PPFA)
|
| Vol #:
|
| 6
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
| EXB 28
|
| CVM
|
| Vol #:
|
| 403
|
|
| | | | | | | | |
|
|
| 2000P-1211
|
| Establish Mandatory Pre-Market Safety Testing for GE Foods
|
|
|
| EMC 5824
|
| Elaine Lynch
|
| Vol #:
|
| 789
|
|
|
| EMC 5825
|
| Linda M. Coleman
|
| Vol #:
|
| 789
|
|
|
| EMC 5826
|
| Linda M. Coleman
|
| Vol #:
|
| 789
|
|
|
| EMC 5827
|
| susan McHugh
|
| Vol #:
|
| 789
|
|
|
| EMC 5828
|
| Nathan Haslag
|
| Vol #:
|
| 789
|
|
|
| EMC 5829
|
| Kathy Johnson
|
| Vol #:
|
| 789
|
|
|
| EMC 5830
|
| Cherie Roberts
|
| Vol #:
|
| 789
|
|
|
| EMC 5831
|
| Cherie Roberts
|
| Vol #:
|
| 789
|
|
|
| EMC 5832
|
| Cherie Roberts
|
| Vol #:
|
| 789
|
|
|
| EMC 5833
|
| Cherie Roberts
|
| Vol #:
|
| 789
|
|
|
| EMC 5834
|
| Cherie Roberts
|
| Vol #:
|
| 789
|
|
|
| 2001F-0047
|
| Foodborne pathogens in raw-frozen-cooked-partially cooked
|
|
|
| EMC 478
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| EMC 479
|
| M. Chambers
|
| Vol #:
|
| 8
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| C 1349
|
| M. Wiebe
|
| Vol #:
|
| 209
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
| EMC 173
|
| W. Cofield
|
| Vol #:
|
| 3
|
|
|
| 2002N-0276
|
| Bioterrorism Preparedness; Registration of Food Facilities
|
|
|
| C
221
|
| Fonterra (USA)
|
| Vol #:
|
| 20
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 333
|
| Dr. B. Martini
|
| Vol #:
|
| 6
|
|
|
| 2002V-0415
|
| LAD-01 Medical Laser Product
|
|
|
| VRA
2
|
| HFZ-300 to Norwood Abbey Ltd.
|
| Vol #:
|
| 1
|
|
|
| 2003D-0493
|
| Guidance on Powder Blends and Finished Dosage Units -- Stratified In-Process Dosage Unit Sampling and Assessmen
|
|
|
| EMC
10
Attachment
|
| Facility Automation Management Engineering Systems (FAME Systems)
|
| Vol #:
|
| 3
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| EMC 176
|
| B. Sachau
|
| Vol #:
|
| 7
|
|
|
| EMC 177
|
| T and M Martino
|
| Vol #:
|
| 7
|
|
|
| EMC
178
|
| Cornell University
|
| Vol #:
|
| 7
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
| | | | | | | | |
|
|
| SUP 2
|
| J. Korsmo
|
| Vol #:
|
| 15
|
|
|
| 2003N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point (HAACP); Procedures for the Safe and Sanitary Processing and Importing of Jui
|
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2003P-0029
|
| Remove metered-dose inhalers (MDI) containing moiety albuter
|
|
|
| SUP
7
|
| GlaxoSmithKline (GSK)
|
| Vol #:
|
| 2
|
|
|
| 2003P-0555
|
| Maintain the Electroconvulsive Therapy Device in Class III for All Indications
|
|
|
| C 12
|
| D. Weitz
|
| Vol #:
|
| 2
|
|
|
| 2004D-0182
|
| Guidance for Industry on Combination Products, Timeliness of Premarket Review, Dispute Resolution
|
|
| GDL
1
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004D-0210
|
| Guidance: Clinical Trial Design for Hip Replacement Systems
|
|
|
| GDL
1
|
| Orthopedic Surgical Manufacturers Association
|
| Vol #:
|
| 1
|
|
|
| 2004N-0076
|
| Food and Color Additives and Generally Recognized As Safe Substances; Technical Amendments
|
|
|
| NFR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0087
|
| Request for Comment on Generic Drug Issues
|
|
|
| C
5
|
| Mylan Pharmaceuticals, Inc. (Mylan)
|
| Vol #:
|
| 1
|
|
|
| C
6
|
| Generic Pharmaceutical Association (GPhA)
|
| Vol #:
|
| 1
|
|
|
| EMC
2
|
| Sandoz, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0115
|
| Prescription Drug Importation Study
|
|
|
| C
6
Continued
|
| Covington & Burling
|
| Vol #:
|
| 8
|
|
|
| EMC 10
|
| M. Reidenberg, MD, FACP
|
| Vol #:
|
| 3
|
|
|
| 2004N-0133
|
| Part 11, Electronic Record; Electronic Signatures; Public Meeting
|
|
|
| APE 2
|
| The Hollis Group, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004P-0140
|
| Rescind the March 1, 2004 Dear Applicant Letter Regarding Metaxalone Labeling
|
|
|
| C
1
|
| Corepharma, LLC (Corepharma)
|
| Vol #:
|
| 3
|
|
|
| EMC
2
|
| Corepharma, LLC (Corepharma)
|
| Vol #:
|
| 2
|
|
|
| 2004V-0211
|
| Variance for Mobolazer ML 10 300
|
|
|
| ACK 1
|
| HFA-305 to Dreamspell
|
| Vol #:
|
| 1
|
|
|
| CR 1
|
| HFA-305 to Dreamspell
|
| Vol #:
|
| 1
|
|